Pantoprazole Sodium Tablet, Delayed Release
Product Images NDC 0904-6870

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 0904-6870). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label (De419aa0 Caa9 40fb Bc6d E341c94273c7 00)

Pantoprazole Sodium delayed-release tablets, USP, 40 mg oral tablets in unit dose packaging by Major Pharmaceuticals. The label displays the NDC number 0904-6870-45 and indicates there are 80 tablets included. It has instructions for pharmacist dispensing with a medication guide and storage recommendations. The packaging states Rx only and includes distributor information from Major Pharmaceuticals in Livonia, MI, and Aurobindo Pharma USA, Inc.*

FDA Label Image

Chemical Structure (Pantoprazole Str)

Chemical structure of Pantoprazole Sodium showing two aromatic rings connected by a sulfinyl group, with various functional groups including methoxy, difluoromethoxy, and a sodium ion associated; also includes 1.5 water molecules (hydrate).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.